✦ LIBER ✦

Movement disorders as a manifestation of metronidazole-induced encephalopathy in a patient with chronic liver disease

✍ Scribed by Marcelo Galvez; Javier Brahm; Marcelo Miranda

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 498 KB
Volume: 24
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.22624

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatic encephalopathy as a predictor of

Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease

✍ Charmaine A. Stewart; Michael Malinchoc; W. Ray Kim; Patrick S. Kamath 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

Hepatic encephalopathy (HE) is an important component of hepatic decompensation, which reduces survival in patients with cirrhosis. The Model for End-Stage Liver Disease (MELD) score has been used to predict survival of patients with cirrhosis. The aims of this study were to determine whether HE is

Cryptococcal tonsillitis in a patient wi

Cryptococcal tonsillitis in a patient with chronic lymphocytic leukemia: An unusual manifestation of cryptococcal disease

✍ Joyce Korvick; Victor L. Yu 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 294 KB 👁 2 views

Safety and immunogenicity of hepatitis A

Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease

✍ Emmet B. Keeffe; Sten Iwarson; Brian J. McMahon; Karen L. Lindsay; Raymond S. Ko 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

Acute hepatitis A superimposed on chronic liver disease (CLD) has been associated with severe or fulminant hepatitis. An open, multicenter study was performed to compare the safety and immunogenicity of an inactivated hepatitis A vaccine in patients with CLD with that in healthy subjects. A secondar

Hyperuricemia as a risk factor for contr

Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease

✍ Omer Toprak; Mustafa Cirit; Ertap Esi; Nursen Postaci; Murat Yesil; Serdar Bayat 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB 👁 2 views

Safety and immunogenicity of inactivated

Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease

✍ Lee, Shou-Dong; Chan, Cho-Yu; Yu, May-Ing; Wang, Yuan-Jen; Chang, Full-Young; Lo 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB 👁 2 views

The safety and immunogenicity of inactivated hepatitis A vaccine was evaluated in patients with chronic liver disease. Sixty hepatitis A virus antibody (anti-HAV) seronegative patients with chronic liver disease (56 chronic hepatitis B and four chronic hepatitis C) and from 17 to 47 years of age rec

The prevalence and incidence of cholecys

The prevalence and incidence of cholecystolithiasis in patients with chronic liver diseases: A prospective study

✍ I-Shyan Sheen; Yun-Fan Liaw 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 362 KB

To investigate the prevalence and incidence of cholecystolithiasis in hepatitis B surface antigen-positive chronic liver diseases, a prospective study using hepatobiliary ultrasonography was conducted in 933 "healthy" persons and four groups of HBsAg-positive patients: 226 asymptomatic carriers, 73